Skip to main content

Advertisement

Table 2 Patients characteristics at the time of quaternary debulking surgery (QDS)

From: Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)

Author Year Number FIGO stage (n) Agea Residual disease (n) Median CA125 (U/ml) Chemotherapy (n) Median OS (m)b
Shih et al. 2010 15 I (1) 54.1 0 mm (10) NA Yes (9) 34.8, 10.1 (from TDS)c
II (2)   >0 mm (5)   No (6)  
III (9)      
IV (1)      
Fotopoulou et al. 2013 49 I (6) 57 0 mm (16) 736 Yes (18) 23.05 (from QDS)
II (6)   >0 mm (33)   No (31)  
III (33)      
IV (1)      
Bacarubasa et al. 2015 20 I (4) 54.3 0 mm (7) NA NA 16 (from QDS)
II (5)   >0 mm (13)    
III (11)      
IV (0)      
Hirakawa et al. 2017 11 I (0) 57 0 mm (7) 11.2 (6 cases) Yes (4) 123 (from SDS)
II (1)   >0 mm (2)   No (7)  
III (7)   Missing (2)    
IV (3)      
  1. QDS quaternary debulking surgery, NA data were not available
  2. aThe values are the median age at QDS
  3. bThe values are the median overall survival (OS)
  4. cFor residual disease ≤10 mm, the median OS was 34.8 months; for residual disease >10 mm, the median OS was 10.1 months